FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1078.691.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.691/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 |
| Version | 20231019 |
| Status | active |
| Date | 2023-10-19T01:11:23-04:00 |
| Name | PIM_Glyxambi |
| Title | PIM_Glyxambi |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: Medications containing Glyxambi in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: includes both brand and generic of Empagliflozin/Linagliptin combination),(Exclusion Criteria: Single ingredient drugs of Empagliflozin and Linagliptin) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1078.691",
"meta": {
"versionId": "6",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "Optum Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2023-10-19"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-10-19"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1078.691"
}
],
"version": "20231019",
"name": "PIM_Glyxambi",
"title": "PIM_Glyxambi",
"status": "active",
"date": "2023-10-19T01:11:23-04:00",
"publisher": "Optum Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: Medications containing Glyxambi in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: includes both brand and generic of Empagliflozin/Linagliptin combination),(Exclusion Criteria: Single ingredient drugs of Empagliflozin and Linagliptin)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1151131",
"display": "Oral Product"
},
{
"code": "1151133",
"display": "Pill"
},
{
"code": "1598392",
"display": "empagliflozin / linagliptin"
},
{
"code": "1602106",
"display": "empagliflozin / linagliptin Oral Product"
},
{
"code": "1602107",
"display": "empagliflozin / linagliptin Pill"
},
{
"code": "1602108",
"display": "empagliflozin / linagliptin Oral Tablet"
},
{
"code": "1602109",
"display": "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet"
},
{
"code": "1602110",
"display": "Glyxambi"
},
{
"code": "1602111",
"display": "empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]"
},
{
"code": "1602112",
"display": "empagliflozin / linagliptin Oral Tablet [Glyxambi]"
},
{
"code": "1602113",
"display": "Glyxambi Oral Product"
},
{
"code": "1602114",
"display": "Glyxambi Pill"
},
{
"code": "1602115",
"display": "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"code": "1602118",
"display": "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet"
},
{
"code": "1602119",
"display": "empagliflozin 25 MG / linagliptin 5 MG [Glyxambi]"
},
{
"code": "1602120",
"display": "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"code": "317541",
"display": "Oral Tablet"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:4daa90b6-57f5-4193-9def-9d17b8866046",
"timestamp": "2025-05-23T17:54:45-04:00",
"total": 17,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1151131",
"display": "Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1151133",
"display": "Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1598392",
"display": "empagliflozin / linagliptin"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602106",
"display": "empagliflozin / linagliptin Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602107",
"display": "empagliflozin / linagliptin Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602108",
"display": "empagliflozin / linagliptin Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602109",
"display": "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602110",
"display": "Glyxambi"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602111",
"display": "empagliflozin 10 MG / linagliptin 5 MG [Glyxambi]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602112",
"display": "empagliflozin / linagliptin Oral Tablet [Glyxambi]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602113",
"display": "Glyxambi Oral Product"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602114",
"display": "Glyxambi Pill"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602115",
"display": "empagliflozin 10 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602118",
"display": "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602119",
"display": "empagliflozin 25 MG / linagliptin 5 MG [Glyxambi]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1602120",
"display": "empagliflozin 25 MG / linagliptin 5 MG Oral Tablet [Glyxambi]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "317541",
"display": "Oral Tablet"
}
]
}
}